Dear AuntMinnie Member,
It's no secret that medical imaging procedure volume has taken a hit as hospitals postpone nonemergency studies to deal with the COVID-19 pandemic. A new report illustrates just how seriously radiology has been slammed.
Imaging volumes are down over 50% at practices around the U.S., according to data released on April 23 by market research firm Quinsite. As crazy as it sounds, that may actually represent an improvement -- the firm found imaging volume down 60% in an update 10 days before.
The figures indicate that we're starting to get quantitative data on the impact that COVID-19 is having, both on imaging providers and vendors. First-quarter earnings season is starting, and most companies are beginning to report that COVID-19 is taking a bite out of revenues. The big hit will come in the second quarter, however, as purchasing activity ground to a halt in April.
But the COVID-19 pandemic isn't going to last forever. Some key opinion leaders are even beginning to raise the possibility that a surge of patients needing imaging exams could occur as the outbreak winds down. But is radiology ready?
Other recent developments on the COVID-19 front include a notice from the U.S. Food and Drug Administration that it would be lifting some of its regulatory oversight for modifications made to imaging equipment in light of the pandemic. The announcement came as many imaging facilities are finding creative ways to image patients with suspected COVID-19 while minimizing infection risk.
Meanwhile, clinicians issued a warning about using CT to diagnose COVID-19, while a group from Italy found that performing quantitative measurements of the well-aerated lung on baseline CT scans can predict prognosis in patients with COVID-19 pneumonia.
Finally, there will be several presentations on COVID-19 in our 2020 Virtual Conference, being held on April 30 and May 1. Have you registered yet? Join over 4,000 radiology professionals who have at auntminnie.vfairs.com.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
